active portfolio companies. Mr. Kreis is also a founding member of Cowtown Angels, a Fort Worth-based angel investment network. Prior to this, Mr. Kreis was a Vice President at HBK Investments, a multi-strategy global hedge fund based in Dallas, Texas. Mr. Kreis received a BBA in Finance...
“This joint venture marks a promising beginning,” said Liu Yi, Senior Vice President of Fosun Pharma, Chairman and CEO of Fosun MedTech. “We believe that Insightec’s technological innovation strength in the international market, combined with Fosun Pharma’s clinical practice advantages in domes...
Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings a
At the conference, Pirovolakis met Steven Gray, Ph.D., of the UT Southwestern Medical Center in Dallas. Pirovolakis eventually hired Gray to develop an investigational therapy. After it was tested successfully in mice and monkeys, Health Canada and the FDA approved it for use in a trial. Mi...
Pharma Focus Asia, published by Ochre Media, is the leading pharma title in print and digital versions serving the information needs of key executives from the worlds leading pharmaceutical companies.
DALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development, today announced that the FDA has granted Fast Track...
A pharmaceutical digital marketing agency is a specialized firm that focuses on helping pharmaceutical companies market their products through digital channels. This includes creating digital strategies, SEO, content marketing, email marketing, social media marketing, and more. These agencies have an in-...
A Dallas-based biotech company is leading a wave of innovation in cancer treatment that is being tailored to the cancer patients who are most likely to respond.
Prior to AstraZeneca, Ginkel served as a consultant in market research for pharmaceutical companies and worked at biotech in molecular biology. David has a Master’s from the University of Texas Southwestern in Dallas and an MBA from Thunderbird International Business School (Arizona State University...
Lantern Pharma, a tiny startup in Dallas, is helping to rescue failed cancer drugs with the application of neural networks. It's not deep learning, but it shows that very basic machine learning can be a valuable tool for life sciences. ...